Jaguar Health Announces Completion of Preclinical Studies of Lechlemer, the Company's Human Drug Product Candidate for Cholera and Acute Infectious Diarrhea
Stock Information for Jaguar Health Inc.
Loading
Please wait while we load your information from QuoteMedia.